Completed
A key objective of medicines regulatory authorities is to protect public health by ensuring the quality, safety and efficacy of medicines. Medicines regulatory authorities use mutual recognition/reliance agreements and informal practices of recognition/reliance in various range and approaches. At the request of the U.S. Food and Drug Administration's Office of International Programs, the National Academies have convened a committee to analyze and assess how the regulatory authorities of different countries use such regulatory practices and will evaluate their effects on public health, use of resources, and essential regulatory competencies.
Events
Meetings
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People